Cyberkinetics

From Wikipedia, the free encyclopedia
Jump to: navigation, search
BrainGate.jpg

Cyberkinetics is an American company with roots tied to the University of Utah. It was co-founded by John Donoghue, Mijail Serruya, and Gerhard Friehs of Brown University and Nicho Hatsopoulos of the University of Chicago. The Braingate technology and related Cyberkinetic’s assets were acquired by Blackrock Microsystems, LLC in 2008. Blackrock Microsystems[1] is a privately held company that provides enabling tools for the neuroscience, neural engineering, and neuroprosthetics research and clinical community worldwide. Blackrock boasts the largest portfolio of FDA and CE cleared systems for human use in world. Our R&D efforts consistently raise the bar on data quality through such innovations as wireless technologies, miniaturization, ultra-high channel densities and low noise. Blackrock's headquarters are in the University of Utah's Research Park in Salt Lake City, UT.

Funding[edit]

Scientists behind the project used $9.3 million in first round funding led by Oxford Bioscience Partners. A 2002 merger with Bionic Technologies, co-founded by Brian Hatt and Richard Normann (the inventor of the Utah Array) added to a tech team armed with intellectual property rights gained from Brown, MIT, and others. They say they're three to five years away from putting a product on the market.

According to their latest SEC filing, the Founders of the company resigned from the Board of Directors at the end of October, 2008.

Merger & Renaming[edit]

In late 2004, Cyberkinetics initiated a reverse merger with a Texas company in order to gain access to the public market. The resulting company was renamed Cyberkinetics Neurotechnology Systems, Inc. and its shares are listed under the symbol CYKN.OB. In 2009, the BrainGate business and related Cyberkinetic’s assets were sold to privately held Braingate, LLC.[2]

In early 2009, Cyberkinetics was acquired by Blackrock Microsystems, LLC.[3]

Clinical Trials[edit]

Update: July 8, 2009 Clinical Trials are now being conducted for the Brain Gate 2 Neural Interface System. Additional information on Brain Gate can be accessed at www.braingate2.org[4]

Update: July 16, 2009 The pilot clinical trial of the BrainGate2 Neural Interface System is registered at ClinicalTrials.gov; details can be viewed here [4][5]

Competitors[edit]

See also[edit]

References[edit]

  1. ^ "neuroscience research systems - empowering electrophysiology". blackrockmicro.com. 
  2. ^ Braingate gets a new lease on life, The Boston Globe, August, 2009
  3. ^ "Blackrock Microsystems Obtains Expanded 510(k) to Market NeuroPort System". PRWeb. 15 July 2009. 
  4. ^ a b "BrainGate - Home". Braingate2.org. 
  5. ^ "BrainGate2: Feasibility Study of an Intracortical Neural Interface System for Persons With Tetraplegia - Full Text View". ClinicalTrials.gov. 

External links[edit]